Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study

Importance The identification of a subgroup at higher risk of melanoma may assist in early diagnosis. Objective To characterize melanoma patients and the clinical features associated with their melanomas according to patient risk factors: many nevi, history of previous melanoma, and family history of melanoma, to assist with improving the identification and treatment of a higher-risk subgroup. Design, Setting, and Participants The Melanoma Patterns of Care study was a population-based observational study of physicians’ reported treatment of 2727 patients diagnosed with an in situ or invasive primary melanoma over a 12-month period from October 2006 to 2007 conducted in New South Wales. Our analysis of these data took place from 2015 to 2016. Main Outcomes and Measures Age at diagnosis and body site of melanoma. Results Of the 2727 patients with melanoma included, 1052 (39%) were defined as higher risk owing to a family history of melanoma, multiple primary melanomas, or many nevi. Compared with patients with melanoma who were at lower risk (ie, without any of these risk factors), the higher-risk group had a younger mean age at diagnosis (62 vs 65 years, P < .001), but this differed by risk factor (56 years for patients with a family history, 59 years for those with many nevi, and 69 years for those with a previous melanoma). These age differences were consistent across all body sites. Among higher-risk patients, those with many nevi were more likely to have melanoma on the trunk (41% vs 29%, P < .001), those with a family history of melanoma were more likely to have melanomas on the limbs (57% vs 42%, P < .001), and those with a personal history were more likely to have melanoma on the head and neck (21% vs 15%, P = .003). Conclusions and Relevance These findings suggest that a person’s risk factor status could be used to tailor surveillance programs and education about skin self-examination.

[1]  G J Mann,et al.  Clinical practice guidelines for identification, screening and follow‐up of individuals at high risk of primary cutaneous melanoma: a systematic review , 2015, The British journal of dermatology.

[2]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[3]  A. Chompret,et al.  Comparison between familial and nonfamilial melanoma in France. , 1995, Archives of dermatology.

[4]  W. Clark,et al.  High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. , 1985, Annals of internal medicine.

[5]  C. Garbe,et al.  Is head and neck melanoma a distinct entity? A clinical registry‐based comparative study in 5702 patients with melanoma , 2006, The British journal of dermatology.

[6]  C. Muir,et al.  International Classification of Diseases for Oncology , 1990 .

[7]  Douglas G Altman,et al.  [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. , 2007, Gaceta sanitaria.

[8]  Michael P Schön,et al.  Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas. , 2016, JAMA dermatology.

[9]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. , 2005, European journal of cancer.

[10]  J. Barrett,et al.  Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors. , 2016, JAMA dermatology.

[11]  Jacques Ferlay,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .

[12]  J. Emery,et al.  Development and Validation of a Family History Screening Questionnaire in Australian Primary Care , 2014, The Annals of Family Medicine.

[13]  F. Sera,et al.  Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. , 2009, European journal of cancer.

[14]  S. Florell,et al.  Comparative Analysis of Total Body and Dermatoscopic Photographic Monitoring of Nevi in Similar Patient Populations at Risk for Cutaneous Melanoma , 2010, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[15]  L. Fritschi,et al.  Characteristics of familial and non-familial melanoma in Australia , 1998, Melanoma research.

[16]  J. Malvehy,et al.  Melanomas detected in a follow-up program compared with melanomas referred to a melanoma unit. , 2011, Archives of dermatology.

[17]  Matthias Egger,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.

[18]  Graham A Colditz,et al.  Risk factors and individual probabilities of melanoma for whites. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  N. Hayward,et al.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.

[20]  S. Rosso,et al.  Inherited Genetic Variants Associated with Occurrence of Multiple Primary Melanoma , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[21]  E. Holly,et al.  Incidence of cutaneous melanoma among non-Hispanic Whites, Hispanics, Asians, and Blacks: an analysis of California Cancer Registry data, 1988-93 , 1997, Cancer Causes & Control.

[22]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.

[23]  J. Malvehy,et al.  Characterization of 1152 lesions excised over 10 years using total-body photography and digital dermatoscopy in the surveillance of patients at high risk for melanoma. , 2012, Journal of the American Academy of Dermatology.

[24]  V. Siskind,et al.  Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia. , 2012, Archives of dermatology.

[25]  E. Scott,et al.  The anatomical distribution of skin cancers. , 1986, International journal of epidemiology.

[26]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[27]  Shou-En Lu,et al.  Skin self-examination and long-term melanoma survival , 2016, Melanoma research.

[28]  J. Aitken,et al.  Clinical practice guidelines for the management of melanoma in Australia and New Zealand , 2008 .

[29]  Pascale Guitera,et al.  Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. , 2014, JAMA dermatology.

[30]  J. Lortet-Tieulent,et al.  International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? , 2013, International journal of cancer.